Health ❯ Healthcare

Patient Outcomes

Survival Rates Quality of Life Treatment Efficacy Mortality Rates Progression-Free Survival Adverse Events Weight Loss Efficacy Studies Weight Management Response Rates

7 ARTICLES

13h ago

Survodutide Shows Large Liver and Visceral Fat Loss in Phase 3 Trials

New results shift attention from pounds lost to where fat is lost and set up more analyses to test whether that benefit will change clinical and commercial comparisons.

Stories older than 24h

4 ARTICLES

2d ago

Roche Stops Phase 3 for Acmopatide After Positive Phase 2 in Type 1 Diabetes

5 ARTICLES

2d ago

Finerenone Slows Kidney Decline in Non‑Diabetic CKD, Trial Shows

3 ARTICLES

5d ago

UC Study Links Some Antibody‑Drug Conjugates to High Rates of Severe Neutropenia

12 ARTICLES

last wk.

Ivonescimab Extends Survival in China Phase 3 Trial for Squamous Lung Cancer

5 ARTICLES

last wk.

Erleada Plus Hormone Therapy Cuts Recurrence and Death in High‑Risk Localized Prostate Cancer

5 ARTICLES

last wk.

Implanted Cesium-131 Tiles Cut Recurrences and Boost Survival in ROADS Phase III Trial

6 ARTICLES

last wk.

NHS‑Backed Trial of Galleri Blood Test Fails to Meet Main Goal

35 ARTICLES

2w ago

Lilly’s Triple‑Agonist Retatrutide Produces Surgery‑Level Weight Loss in Phase 3 Trial

3 ARTICLES

2w ago

Cleveland Clinic and Carnegie Mellon Publish AI That Reads Cardiac MRI With Near-Clinical Accuracy

4 ARTICLES

2w ago

Low‑Risk Pancreatic Cysts Linked to Much Higher Long‑Term Cancer Risk

3 ARTICLES

2w ago

ctDNA Blood Test Guides Care as Targeted Radiotherapy Improves Control in Early Metastatic Cancer

3 ARTICLES

3w ago

Two-Session MRI-Guided Radiotherapy Matches Five Visits on Side Effects in Small Prostate Cancer Trial

4 ARTICLES

3w ago

FDA Grants Accelerated Approval to First BCL2 Drug for Relapsed Mantle Cell Lymphoma

27 ARTICLES

3w ago

New Trials Show Daily Pills Can Help Maintain Weight Loss After GLP-1 Injections

6 ARTICLES

3w ago

Personalized DNA Vaccine Shows Strong Immune Response in Early Glioblastoma Study

5 ARTICLES

3w ago

GLP-1 Drugs Linked to Lower Death and Recurrence in Breast Cancer, Large Study Finds

5 ARTICLES

3w ago

Meta-Analysis Backs Low-Dose Digitalis for Heart Failure With Fewer Worsening Events

4 ARTICLES

3w ago

Slow-Cycling ER-Positive Cells Linked to Late Breast Cancer Relapse

4 ARTICLES

4w ago

Patient Outcomes

Survodutide Shows Large Liver and Visceral Fat Loss in Phase 3 Trials

Roche Stops Phase 3 for Acmopatide After Positive Phase 2 in Type 1 Diabetes

Finerenone Slows Kidney Decline in Non‑Diabetic CKD, Trial Shows

UC Study Links Some Antibody‑Drug Conjugates to High Rates of Severe Neutropenia

Ivonescimab Extends Survival in China Phase 3 Trial for Squamous Lung Cancer

Erleada Plus Hormone Therapy Cuts Recurrence and Death in High‑Risk Localized Prostate Cancer

Implanted Cesium-131 Tiles Cut Recurrences and Boost Survival in ROADS Phase III Trial

NHS‑Backed Trial of Galleri Blood Test Fails to Meet Main Goal

Lilly’s Triple‑Agonist Retatrutide Produces Surgery‑Level Weight Loss in Phase 3 Trial

Cleveland Clinic and Carnegie Mellon Publish AI That Reads Cardiac MRI With Near-Clinical Accuracy

Never miss stories about

Patient Outcomes

Low‑Risk Pancreatic Cysts Linked to Much Higher Long‑Term Cancer Risk

ctDNA Blood Test Guides Care as Targeted Radiotherapy Improves Control in Early Metastatic Cancer

Two-Session MRI-Guided Radiotherapy Matches Five Visits on Side Effects in Small Prostate Cancer Trial

FDA Grants Accelerated Approval to First BCL2 Drug for Relapsed Mantle Cell Lymphoma

New Trials Show Daily Pills Can Help Maintain Weight Loss After GLP-1 Injections

Personalized DNA Vaccine Shows Strong Immune Response in Early Glioblastoma Study

GLP-1 Drugs Linked to Lower Death and Recurrence in Breast Cancer, Large Study Finds

Meta-Analysis Backs Low-Dose Digitalis for Heart Failure With Fewer Worsening Events

Slow-Cycling ER-Positive Cells Linked to Late Breast Cancer Relapse

Inhibrx Combo Shows 44% Response vs 21% With Pembrolizumab Alone in First-Line Head and Neck Cancer

Never miss stories about

Patient Outcomes